178 related articles for article (PubMed ID: 18613924)
1. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.
Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA
Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924
[TBL] [Abstract][Full Text] [Related]
2. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Preusser M; Hoeftberger R; Woehrer A; Gelpi E; Kouwenhoven M; Kros JM; Sanson M; Idbaih A; Brandes AA; Heinzl H; Gorlia T; Hainfellner JA; van den Bent M
Histopathology; 2012 May; 60(6):885-94. PubMed ID: 22335622
[TBL] [Abstract][Full Text] [Related]
5. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
6. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
[TBL] [Abstract][Full Text] [Related]
7. [Proliferative activity of ependymomas. (Quantitative analysis of the expression of Ki67 and AgNOR)].
Ferraraccio F; Accardo M; Cuccurullo L
Pathologica; 1995 Apr; 87(2):112-20. PubMed ID: 8532401
[TBL] [Abstract][Full Text] [Related]
8. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
9. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
[TBL] [Abstract][Full Text] [Related]
10. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
11. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.
Wolfsberger S; Fischer I; Höftberger R; Birner P; Slavc I; Dieckmann K; Czech T; Budka H; Hainfellner J
Am J Surg Pathol; 2004 Jul; 28(7):914-20. PubMed ID: 15223962
[TBL] [Abstract][Full Text] [Related]
13. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
[TBL] [Abstract][Full Text] [Related]
14. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
15. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.
Mengel M; von Wasielewski R; Wiese B; Rüdiger T; Müller-Hermelink HK; Kreipe H
J Pathol; 2002 Nov; 198(3):292-9. PubMed ID: 12375261
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Preusser M; Heinzl H; Gelpi E; Schonegger K; Haberler C; Birner P; Marosi C; Hegi M; Gorlia T; Hainfellner JA;
Cancer; 2006 Jul; 107(1):162-70. PubMed ID: 16721804
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.
Grotzer MA; Geoerger B; Janss AJ; Zhao H; Rorke LB; Phillips PC
Med Pediatr Oncol; 2001 Feb; 36(2):268-73. PubMed ID: 11452934
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
Onguru O; Kurt B; Gunhan O; Soylemezoglu F
Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
20. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study.
Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
